Cancer Advances
Subscribe:
Featured Episode
Insights into Advanced Surgical Techniques for Neuroblastoma
Gloria Gonzalez, MD, Pediatric Surgeon and Director of Pediatric Surgical Oncology, joins the Cancer Advances podcast to provide her insights on advanced surgical techniques for neuroblastoma. Listen as Dr. Gonzalez explains the complexities of neuroblastoma, the use of 3D printing in preoperative planning and 3D image-guided surgery, and the emerging role of fluorescent-guided surgery.
Play NowAll Cancer Advances Episodes
March 6, 2025
Integrative Oncology Program
The Cancer Advances podcast is joined by the Chair of the Palliative and Supportive Care Department, Laura Shoemaker, DO, and Integrative Medicine Specialist, Naoki Umeda, MD, to talk about Cleveland Clinic's Integrative Oncology Program. Listen as they share how combining evidence-based complementary therapies, such as acupuncture and lifestyle medicine, with conventional cancer treatment can help alleviate symptoms, enhance patients' quality of life, and improve outcomes.
Play NowFebruary 27, 2025
Bispecific Antibodies and Immunotherapy for Aggressive Lymphomas
Paolo Caimi, MD, Associate BMT Director for Cell Therapy at Cleveland Clinic Cancer Institute, joins the Cancer Advances podcast to discuss the latest advancements in immunotherapy for aggressive lymphomas. Listen as Dr. Caimi talks about the potential of bispecific antibody combinations, including early-phase findings on glofitamab plus ICE chemotherapy for relapsed and refractory diffuse large B-cell lymphoma.
Play NowFebruary 20, 2025
The Potential of CAR T-Cell Therapy for Chronic Lymphocytic Leukemia (CLL)
Vice Chair of the Center for Immunotherapy and Precision Immuno-Oncology, J. Joseph Melenhorst, PhD, joins the Cancer Advances Podcast to discuss the potential of CAR T-cell therapy for chronic lymphocytic leukemia (CLL). Listen as Dr. Melenhorst explains how advancements in cell therapy are overcoming challenges like T cell exhaustion, improving response rates, and how novel approaches could improve treatment outcomes.
Play NowFebruary 13, 2025
Exploring Intermittent Therapy for Metastatic Renal Cell Carcinoma
Moshe Ornstein, MD, MA, a Genitourinary Medical Oncologist joins the Cancer Advances podcast to talk about intermittent therapy for metastatic renal cell carcinoma (mRCC). Listen as Dr. Ornstein explores the evolution of treatment options, from cytokine and targeted therapies to immunotherapy, and as he delves into the promising concept of treatment breaks to improve patient outcomes.
Play Now
